Nu-Med Plus Announces the Addition of Charles Ivester M.D., Ph.D., to Their Medical Advisory Board

SALT LAKE CITY, UTAH--(Marketwired - Apr 28, 2015) - Nu-Med Plus, Inc. (OTCBB: NUMD), a medical device company which explores and develops medical applications of new technologies in the medical field, announced the selection of Charles Ivester M.D., Ph.D. to their Medical Advisory Board.

Dr. Ivester received his Ph.D. and M.D. from the Medical University of South Carolina and is certified in Pulmonary Disease, Internal, Critical Care, and Sleep Medicine while holding licensure as a physician and surgeon in the State of Utah. He has participated in countless research ventures, been published numerous times while presenting his findings at a variety of national and international venues along with serving as an educator/teacher at a number of conferences and medical related schools. Dr. Ivester presently practices as a Pulmonary Intensive care physician at Ogden Pulmonary Associates in Ogden, Utah. "Having Dr. Ivester join our Medical Advisory Board will strengthen our company's ability to focus on high growth existing and impending markets where there are clearly defined needs recognized by the medical community," commented Mr. Jeff Robins, President and CEO of Nu-Med-Plus.

About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a medical device development company created to explore medical applications of newly developed technologies. The strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its technical expertise. Initial research and product development has been in the delivery of inhaled nitric oxide gas for therapeutic use. For more information please visit

Forward-Looking Statements
Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company's control. Such factors include, among other things: risks and uncertainties relating to the Company's ability to complete proposed private placement financing. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

Contact Information:

Jeff Robins